(Q42679616)
Statements
1 reference
Subset analysis of patients experiencing clinical events of a potentially immunogenic nature in the pivotal clinical trials of tocilizumab for rheumatoid arthritis: Evaluation of an antidrug antibody ELISA using clinical adverse event-driven immunog (English)
1 reference
Kay Stubenrauch
1 reference
Uwe Wessels
1 reference
Herbert Birnboeck
1 reference
Francisco Ramirez
1 reference
Angelika Jahreis
1 reference
Julia Schleypen
1 reference
1 August 2010
1 reference
1 reference
32
1 reference
9
1 reference
1597-1609
1 reference
Identifiers
1 reference
1 reference